DEA

The average age of first-time R01 funded investigators who have PhDs remains 42 even after seven years of policies at NIH to increase the numbers of new and early-stage investigators.  And, over the same interval, age has continued to increase for first-time R01-funded MDs and MD-PhDs, despite the policies we have in place. What is going on?

ShareThis: 

I want to share with you part of a recent discussion I had with the Friends of the NIA about the importance of public-private partnerships in aging research.

ShareThis: 

The explosion of Big Data promises to transform biomedical research, but all too often researcher

ShareThis: 

How do I write a grant application that will get funded?

ShareThis: 

Following every meeting of the National Advisory Council on Aging, we set about the task of fundi

ShareThis: 

The deadline is fast approaching for the 2015 Butler-Williams Scholars Program, NIA’s premier aging research training program. Apply by March 27, 2015, and encourage your contacts and friends to do the same.

ShareThis: 

Geroscience—a field that looks at the relationship between aging and disease—has gained lots of traction within the scientific community. I think this is a good thing. Anybody who heard me talk recently would be excused if they were to think that this is now the primary focus of NIA’s Division of Aging Biology… Well, not so! The centerpiece of work funded by the Division of Aging Biology remains basic research into the biological roots of aging. The application of this research to human health and disease is a welcome addition—“icing on the cake,” if you will.

ShareThis: 

There are a handful of run-of-the-mill ‘R’ grants offered by the NIH that are familiar to most investigators: everyone knows the R01. Ever heard of the R34? Not one of those that most people know. The R34 is a “planning grant.”

ShareThis: 

Blog post - supporting aging research in challenging times

Cartoon of four people in conversation.

This is an extremely difficult time in aging research. Dr. Richard J. Hodes, NIA director, describes some of the challenges that lie ahead, as well as what the next fiscal year will bring. “While the scientific and fiscal challenges are very real, it is still an exciting time to be in aging and Alzheimer’s research,” writes Dr. Hodes.

Subscribe to RSS - DEA